Chemoinformaics analysis of 1,3-Dihydroxy-4,7-dimethoxyxanthone
| Molecular Weight | 288.255 | nRot | 2 |
| Heavy Atom Molecular Weight | 276.159 | nRig | 17 |
| Exact Molecular Weight | 288.063 | nRing | 3 |
| Solubility: LogS | -3.7 | nHRing | 1 |
| Solubility: LogP | 2.773 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 6 | APOL | 37.8635 |
| nHD | 2 | BPOL | 18.1145 |
| QED | 0.704 |
| Synth | 2.354 |
| Natural Product Likeliness | 1.264 |
| NR-PPAR-gamma | 0.89 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.108 |
| Pgp-sub | 0.003 |
| HIA | 0.022 |
| CACO-2 | -4.898 |
| MDCK | 0.0000154 |
| BBB | 0.012 |
| PPB | 0.881264 |
| VDSS | 0.856 |
| FU | 0.150453 |
| CYP1A2-inh | 0.97 |
| CYP1A2-sub | 0.96 |
| CYP2c19-inh | 0.313 |
| CYP2c19-sub | 0.114 |
| CYP2c9-inh | 0.617 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.549 |
| CYP2d6-sub | 0.749 |
| CYP3a4-inh | 0.404 |
| CYP3a4-sub | 0.186 |
| CL | 5.272 |
| T12 | 0.712 |
| hERG | 0.009 |
| Ames | 0.708 |
| ROA | 0.259 |
| SkinSen | 0.732 |
| Carcinogencity | 0.102 |
| EI | 0.908 |
| Respiratory | 0.365 |
| NR-Aromatase | 0.811 |
| Antiviral | Yes |
| Prediction | 0.687742 |